Stock PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Real-time Estimate Cboe BZX
Other stock markets
 17:42:32 01/05/2024 BST 		5-day change 1st Jan Change
1.635 USD -0.91% Intraday chart for Pacific Biosciences of California, Inc. +22.04% -83.08%
04-22 JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight MT
04-18 Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries
AQ
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
PR
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PR
PacBio Grants Equity Incentive Award to New Employee
PR
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
PR
PacBio to Present at Upcoming Investor Conferences
PR
Federal Circuit Affirms Claim Construction And How It Applies
AQ
Pacific Biosciences: Q4 Earnings Snapshot
AQ
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
PR
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch
PR
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
PR
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
PR
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
PR
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
PR
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR
PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors
PR
PacBio to Present at Upcoming Investor Conferences
PR
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
PR
PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
PR
Pacific Biosciences: Q3 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. News Pacific Biosciences of California, Inc.
  5. Press Releases